To investigate the potential of HDAC1-3 inhibitions in cancer therapy, we analyzed the expression and prognostic value of HDAC1, 2, and 3 in various cancers using the GEPIA2 web tool based on The Cancer Genome Atlas database [26]. The gene discussed is HDAC1; the disease is cancer.